Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy at 3 Months on Permanent Atrial Fibrillation in Patients Candidates to Cardiac Surgical Treatment by Epicardial, or Possibly Endocardial, Radiofrequency Ablation

NCT00259623 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT00259623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00259623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy at 3 Months on Permanent Atrial Fibrillation in Patients Candidates to Cardiac Surgical Treatment by Epicardial, or Possibly Endocardial, Radiofrequency Ablation
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2005
Completion date
October 31, 2007
Enrollment
13 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation